Answers are grounded in this paper and cite their sources.
Ischemia-reperfusion injury (IRI) remains as a critical challenge for organ transplantation. Herein, an enzyme therapeutic based on superoxide dismutase and catalase for effective mitigation of IRI and pathogen-induced liver injury is reported, providing a therapeutic for organ transplantation and other diseases.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: